If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBritish American Tobacco Regulatory News (BATS)

Share Price Information for British American Tobacco (BATS)

Share Price is delayed by 15 minutes
Get Live Data
4,593.00    -41.00 (-0.88%)
Bid:
4,591.00
Ask:
4,593.00
Spread: 2.00 (0.044%)
Market Cap: £93.08b
BATS Live PriceLast checked at - London Stock Exchange

Intraday British American Tobacco Share Chart

Directorate Change

4 Dec 2023 09:24

RNS Number : 5493V
British American Tobacco PLC
04 December 2023
 

British American Tobacco p.l.c.

 

4 December 2023 

 

 

Directorate Change

Serpil Timuray joins the Board of British American Tobacco p.l.c. as an independent Non-Executive Director with effect from 4 December 2023 and as a member of the Nominations and Remuneration Committees.

Serpil is currently the CEO of Europe Cluster and a member of the Executive Committee at Vodafone Group. She joined Vodafone in 2009 and has held a variety of executive roles being the Group Chief Commercial Operations and Strategy Officer in charge of areas including global strategy, marketing, innovation and digital transformation, the Regional CEO for AMAP (Africa, Middle East, Asia, Pacific), and the CEO of Turkey. Prior to joining Vodafone, Serpil was the CEO of Danone Dairy Turkey, having started her career in 1991 at Procter & Gamble where she held several marketing roles. Serpil is currently Non-Executive Director of TPG Telecom Plc. She previously served as an independent Non-Executive Director of Danone Group Plc from 2015 to 2023 and as the Chair of the Corporate Social Responsibility Committee.

Commenting on the appointment, Luc Jobin, Chair of the Board, said: "I am pleased to welcome Serpil Timuray to our board. Her extensive experience in growing consumer and enterprise product companies in technology and fast-moving consumer goods sectors, and in managing global strategy, innovation and digital transformation will be beneficial to the Board as we continue to accelerate our strategy to build A Better Tomorrow".

Enquiries:

British American Tobacco Press Office+44 (0) 20 7845 2888 (24 hours) | @BATPress 

 

British American Tobacco Investor RelationsVictoria Buxton/Amy Chamberlain/ Yetunde Ibe/John Harney/Jane Henderson+44 20 7845 2012/1124/1095/1263/1117

 

Additional information

1. This announcement is made in compliance with the Company's obligations under Listing Rule 9.6.11.

2. In accordance with the Listing Rules, Serpil Timuray is Non-Executive Director of TPG TELECOM Plc and was previously a director of Danone Group plc. There are no additional matters that would require disclosure under 9.6.13R of the Listing Rules of the UK Financial Conduct Authority in respect of his appointment.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUPGQCPUPWURC
Date   Source Headline
14th Apr 20267:00 amRNSTransaction in Own Shares
13th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 202612:00 pmRNSDirector/PDMR Shareholding
10th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 202611:45 amRNSDirector/PDMR Shareholding
9th Apr 20267:05 amRNSTransaction in Own Shares
9th Apr 20267:00 amRNSDirectorate change
8th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20262:35 pmRNSTotal Voting Rights and Issue of Shares
1st Apr 20262:30 pmRNSDirector/PDMR Shareholding
1st Apr 202611:05 amRNSDirector/PDMR Shareholding
1st Apr 202611:00 amRNSDirector/PDMR Shareholding
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 202612:00 pmRNSDirector/PDMR Shareholding
30th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20262:40 pmRNSDirector/PDMR Shareholding
25th Mar 20262:35 pmRNSDirector/PDMR Shareholding
25th Mar 20262:30 pmRNSDirector/PDMR Shareholding
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 202612:00 pmRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20264:10 pmRNSDirector/PDMR Shareholding
20th Mar 20264:05 pmRNSDirector/PDMR Shareholding
20th Mar 20264:00 pmRNSDirector/PDMR Shareholding
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 202611:35 amRNSPublication of a Prospectus
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20264:00 pmRNSIssue of Shares
17th Mar 20267:05 amRNSTransaction in Own Shares
17th Mar 20267:05 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSBranch Register: Dividend Finalisation Information
17th Mar 20267:00 amRNSBranch Register: Dividend Finalisation Information
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 202612:30 pmRNSNotice of AGM
10th Mar 202612:30 pmRNSNotice of AGM
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 202612:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.